Newsfile Corp 2025-11-12 CSE Bulletin: Delist - Beyond Oil Ltd. (BOIL)
GlobeNewswire 2025-11-12 Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cance...
GlobeNewswire 2025-11-12 Byrna Technologies Named in Forbes’ America’s Most Successful Small-Cap Companies List
GlobeNewswire 2025-11-12 Firefly Neuroscience Reports Third Quarter 2025 Financial Results
GlobeNewswire 2025-11-10 PXG Honors the U.S. Marine Corps’ 250th Birthday & Veterans Day with Special-Edition Collection
GlobeNewswire 2025-11-07 Bright Mountain Media, Inc. Announces Third Quarter 2025 Financial Results
Newsfile Corp 2025-11-07 CSE Bulletin: Delist - Eagle Royalties Ltd. (ER)
Newsfile Corp 2025-11-06 CSE Bulletin: New Listing - Stinger Resources Inc. (STNG)
Newsfile Corp 2025-11-06 CSE Bulletin: Fundamental Change - Blackbird Critical Metals Corp./LIR Life Sciences Corp.
GlobeNewswire 2025-11-06 Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data f...
GlobeNewswire 2025-11-05 Byrna Technologies Featured in Newsweek as Demand for Less-Lethal Solutions Rises Nationally
GlobeNewswire 2025-11-04 Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
Newsfile Corp 2025-11-04 CSE Bulletin: Stock Split - New Earth Resources Corp. - (EATH)
Newsfile Corp 2025-11-03 CSE Bulletin: Delist - Global Helium Corp. (HECO)
GlobeNewswire 2025-10-30 Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14...
GlobeNewswire 2025-10-30 Banco Santander-Chile Announces Third Quarter 2025 Earnings
GlobeNewswire 2025-10-30 Banco Itaú Chile Announces Third Quarter 2025 Management Commentary
GlobeNewswire 2025-10-29 Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
GlobeNewswire 2025-10-29 DEBRA Research Invests in Eliksa Therapeutics to Advance ELK-003, a Biological Eye Drop for Epidermo...
Newsfile Corp 2025-10-28 CSE Bulletin: Fundamental Change - QNB Metals Inc./ReSolve Energy Inc.
GlobeNewswire 2025-10-28 Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting...
GlobeNewswire 2025-10-28 Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Sev...
Newsfile Corp 2025-10-27 CSE Bulletin: New Listing - CAT Strategic Metals Corporation 21NOV2025 Rights (CAT.RT)
GlobeNewswire 2025-10-27 Harvard-Stanford Study Features Byrna as the Exclusive Product Used to Measure Shift in Gun-Owner At...
GlobeNewswire 2025-10-23 Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer